That triple mechanism makes it the most powerful weight loss peptide in clinical development, with phase 2 trial participants losing up to 24.2% of their body weight at the highest dose
The result is nausea, bloating, and sometimes vomiting
Svensson explains the precursor processing that allows one gene to produce different peptides in different tissues and how this context specificity supports precise physiological responses
Key Facts Roche said patients taking its experimental once-daily oral drug, CT-996, for four weeks lost an average of 6.1% of their starting bodyweight compared to patients who received a placebo
Nicholls SJ, Tofe S, le Roux CW, DAlessio DA, Wiese RJ, Pavo I, Brown K, Weerakkody GJ, Zeytinoglu M, Romera IC
Nov 18, 2025 2 min read Lets get the bad news out of the way : many patients shedding pounds with glp-1 drugs like Ozempic, Wegovy, Zepbound may also experience unwanted shedding - their hair